Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005028 · ClinicalTrials.gov registry record · Phase 2

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

A Phase 2 study of Prostate Cancer, sponsored by University of Maryland, Baltimore.

Completed
Registry status
Phase 2
Development phase
46
Enrollment target
4
Study locations

NCT00005028 is a Phase 2 study of Prostate Cancer that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 46 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005028, a Phase 2 study of Prostate Cancer, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
Phase 2
Development phase
46 participants
Enrollment target
4
Study locations

Study Summary

Phase II trial to study the effectiveness of combining paclitaxel and bryostatin 1 in treating patients who have metastatic prostate cancer that has not responded to hormone therapy. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Conditions Studied

Prostate Cancer

Interventions

  • DRUG paclitaxel
  • DRUG bryostatin 1

Study Locations (4)

Pennsylvania

  • Fox Chase Cancer Center - Philadelphia
  • Wellspan Health - York Cancer Center - York

Maryland

  • Greater Baltimore Medical Center and Cancer Center - Baltimore

North Carolina

  • Comprehensive Cancer Center at Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2000-05
Est. Completion 2006-07
Phase Phase 2

Sponsor

University of Maryland, Baltimore

560 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00005028

The ClinicalTrials.gov registry entry for NCT00005028 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which paclitaxel is the first listed.

NCT00005028 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Maryland, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00005028 about?

NCT00005028 is a clinical study titled "Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer". Phase II trial to study the effectiveness of combining paclitaxel and bryostatin 1 in treating patients who have metastatic prostate cancer that has not responded to hormone therapy. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combinin...

What is the current status of trial NCT00005028?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2000-05. Estimated completion is 2006-07.

What conditions does trial NCT00005028 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00005028?

The interventions under investigation include: paclitaxel (DRUG), bryostatin 1 (DRUG).

Who is sponsoring clinical trial NCT00005028?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005028 being conducted?

This trial has 4 study locations across Maryland, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.